{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:25:23Z","timestamp":1777623923392,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05322-5","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T09:58:38Z","timestamp":1680688718000},"page":"1525-1529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Racial disparities in comorbidities of patients with psoriatic arthritis"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1466-8960","authenticated-orcid":false,"given":"Y.","family":"Ross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Jaleel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6520-5619","authenticated-orcid":false,"given":"M.","family":"Magrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"5322_CR1","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376:2095\u20132096","journal-title":"N Engl J Med"},{"key":"5322_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/acr.23094","volume":"69","author":"K Jafri","year":"2017","unstructured":"Jafri K, Bartels CM, Shin D, Gelfand JM, Ogdie A (2017) Incidence and management of cardiovascular risk factors in psoriatic arthritis and rheumatoid arthritis: a population-based study. Arthritis Care Res (Hoboken) 69:51\u201357","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"5322_CR3","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s10067-014-2763-3","volume":"34","author":"GS Kerr","year":"2015","unstructured":"Kerr GS, Qaiyumi S, Richards J, Vahabzadeh-Monshie H, Kindred C, Whelton S, Constantinescu F (2015) Psoriasis and psoriatic arthritis in African-American patients\u2013the need to measure disease burden. Clin Rheumatol 34(10):1753\u20131759","journal-title":"Clin Rheumatol"},{"issue":"4","key":"5322_CR4","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s40744-021-00370-4","volume":"8","author":"A Ogdie","year":"2021","unstructured":"Ogdie A, Matthias W, Thielen RJ, Chin D, Saffore CD (2021) Racial differences in prevalence and treatment for psoriatic arthritis and ankylosing spondylitis by insurance coverage in the USA. Rheumatol Ther 8(4):1725\u20131739","journal-title":"Rheumatol Ther"},{"issue":"2","key":"5322_CR5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/BOR.0000000000000152","volume":"27","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Schwartzman S, Husni ME (2015) Recognizing and managing comorbidities in psoriatic arthritis. Curr Opin Rheumatol 27(2):118\u2013126","journal-title":"Curr Opin Rheumatol"},{"key":"5322_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108397","volume":"214","author":"LM Perez-Chada","year":"2020","unstructured":"Perez-Chada LM, Merola JF (2020) Comorbidities associated with psoriatic arthritis: Review and update. Clin Immunol 214:108397","journal-title":"Clin Immunol"},{"issue":"5","key":"5322_CR7","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/jdv.12742","volume":"29","author":"E Edson-Heredia","year":"2015","unstructured":"Edson-Heredia E, Zhu B, Lefevre C, Wang M, Barrett A, Bushe CJ, Cox A, Wu JJ, Maeda-Chubachi T (2015) Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using clinical practice research datalink. J Eur Acad Dermatol Venereol 29(5):955\u2013963","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"5322_CR8","first-page":"122","volume":"25","author":"J Kaine","year":"2019","unstructured":"Kaine J, Song X, Kim G, Hur P, Palmer JB (2019) Higher incidence rates of comorbidities in patients with psoriatic arthritis compared with the general population using U.S. administrative claims data. J Manag Care Spec Pharm 25(1):122\u2013132","journal-title":"J Manag Care Spec Pharm"},{"issue":"12","key":"5322_CR9","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/acr.20627","volume":"63","author":"JA Husted","year":"2011","unstructured":"Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ et al (2011) Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res 63(12):1729\u20131735","journal-title":"Arthritis Care Res"},{"issue":"8","key":"5322_CR10","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.37765\/ajmc.2020.44075","volume":"26","author":"EJ Maksabedian Hernandez","year":"2020","unstructured":"Maksabedian Hernandez EJ, Tkacz J, Lopez-Gonzalez L, Higgins K, Ogdie A, Stolshek BS (2020) Psoriatic arthritis treatment patterns and costs among pharmacologic treatment-na\u00efve patients. Am J Manag Care 26(8):e252\u2013e257","journal-title":"Am J Manag Care"},{"key":"5322_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3899\/jrheum.150640","volume":"93","author":"D Simone","year":"2015","unstructured":"Simone D, Nowik M, Gremese E, Ferraccioli GF (2015) Disease-modifying antirheumatic drugs (DMARD) and combination therapy of conventional DMARD in patients with spondyloarthritis and psoriatic arthritis with axial involvement. J Rheumatol Suppl 93:65\u201369","journal-title":"J Rheumatol Suppl"},{"key":"5322_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jaut.2016.10.009","volume":"76","author":"SP Raychaudhuri","year":"2017","unstructured":"Raychaudhuri SP, Wilken R, Sukhov AC, Raychaudhuri SK, Maverakis E (2017) Management of psoriatic arthritis: early diagnosis, monitoring of disease severity and cutting edge therapies. J Autoimmun 76:21\u201337","journal-title":"J Autoimmun"},{"issue":"2","key":"5322_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00296-020-04775-2","volume":"41","author":"S Gupta","year":"2021","unstructured":"Gupta S, Syrimi Z, Hughes DM, Zhao SS (2021) Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatol Int 41(2):275\u2013284","journal-title":"Rheumatol Int"},{"issue":"1","key":"5322_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/ijms19010058","volume":"19","author":"L Puig","year":"2017","unstructured":"Puig L (2017) Cardiometabolic comorbidities in psoriasis and psoriatic arthritis. Int J Mol Sci 19(1):58","journal-title":"Int J Mol Sci"},{"key":"5322_CR15","first-page":"151","volume":"9","author":"XS Ren","year":"1999","unstructured":"Ren XS, Amick BC, Williams DR (1999) Racial\/ethnic disparities in health: the interplay between discrimination and socioeconomic status. Ethn Dis 9:151\u2013165","journal-title":"Ethn Dis"},{"issue":"11","key":"5322_CR16","first-page":"16","volume":"7","author":"AF Alexis","year":"2014","unstructured":"Alexis AF, Blackcloud P (2014) Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances. J Clin Aesthet Dermatol 7(11):16\u201324","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"5322_CR17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.22185","volume":"66","author":"M Labitigan","year":"2014","unstructured":"Labitigan M, Bah\u010de-Altuntas A, Kremer JM, Reed G, Greenberg JD, Jordan N, Putterman C, Broder A (2014) Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res (Hoboken) 66(4):600\u2013607","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"5322_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.semarthrit.2006.09.001","volume":"36","author":"O Kimhi","year":"2007","unstructured":"Kimhi O, Caspi D, Bornstein NM, Maharshak N, Gur A, Arbel Y, Comaneshter D, Paran D, Wigler I, Levartovsky D, Berliner S, Elkayam O (2007) Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum 36(4):203\u2013209","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"5322_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/1573403X11666141122220003","volume":"11","author":"G Graham","year":"2015","unstructured":"Graham G (2015) Disparities in cardiovascular disease risk in the United States. Curr Cardiol Rev 11(3):238\u2013245","journal-title":"Curr Cardiol Rev"},{"issue":"7","key":"5322_CR20","first-page":"623","volume":"24","author":"JA Walsh","year":"2018","unstructured":"Walsh JA, Adejoro O, Chastek B, Palmer JB, Hur P (2018) Treatment patterns among patients with psoriatic arthritis treated with a biologic in the United States: descriptive analyses from an administrative claims database. J Manag Care Spec Pharm 24(7):623\u2013631","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"5322_CR21","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s12325-016-0312-y","volume":"33","author":"B Chastek","year":"2016","unstructured":"Chastek B, White J, Van Voorhis D, Tang D, Stolshek BS (2016) A retrospective cohort study comparing utilization and costs of biologic therapies and JAK inhibitor therapy across four common inflammatory indications in adult US managed care patients. Adv Ther 33(4):626\u2013642","journal-title":"Adv Ther"},{"issue":"12","key":"5322_CR22","first-page":"1236","volume":"20","author":"A Howe","year":"2014","unstructured":"Howe A, Eyck LT, Dufour R, Shah N, Harrison DJ (2014) Treatment patterns and annual drug costs of biologic therapies across indications from the Humana commercial database. J Manag Care Spec Pharm 20(12):1236\u20131244","journal-title":"J Manag Care Spec Pharm"},{"key":"5322_CR23","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3899\/jrheum.181019","volume":"47","author":"DK Singh","year":"2020","unstructured":"Singh DK, Magrey MN (2020) Racial differences in clinical features and comorbidities in ankylosing spondylitis in the United States. J Rheumatol 47:835\u2013838","journal-title":"J Rheumatol"},{"issue":"4","key":"5322_CR24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00296-014-2954-x","volume":"34","author":"RJ Curbelo","year":"2014","unstructured":"Curbelo RJ, Loza E, de Y\u00e9benes MJ, Carmona L (2014) Databases and registers: useful tools for research, no studies. Rheumatol Int 34(4):447\u2013452","journal-title":"Rheumatol Int"},{"issue":"1","key":"5322_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1053\/j.pcsu.2010.02.007","volume":"13","author":"WG Williams","year":"2010","unstructured":"Williams WG (2010) Uses and limitations of registry and academic databases. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 13(1):66\u201370. https:\/\/doi.org\/10.1053\/j.pcsu.2010.02.007","journal-title":"Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05322-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05322-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05322-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T17:04:39Z","timestamp":1686589479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05322-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["5322"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05322-5","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,5]]},"assertion":[{"value":"22 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}